Screening for the Human Immunodeficiency Virus (HIV) Infection | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its HIV screening coverage policy, effective May 15, 2026. Here's what billing teams need to know before that date.

CMS HIV screening coverage policy has been updated under a Modified change type, effective May 15, 2026. The Centers for Medicare & Medicaid Services governs this benefit under its preventive services framework, which means the coverage and billing rules carry significant financial exposure for any practice billing HIV screening to Medicare beneficiaries. This policy does not list specific CPT or HCPCS codes in the available policy data—but that doesn't reduce your obligation to bill correctly. If anything, it raises it.

Quick-Reference Table

CMS HIV Screening Coverage Criteria and Medical Necessity Requirements 2026

Medicare covers HIV screening as a preventive service for beneficiaries under specific eligibility criteria. This is a zero cost-sharing benefit when billed correctly—meaning your patients owe nothing, and your practice gets reimbursed only if you bill it right.

The core medical necessity framework for CMS HIV screening has historically covered three groups: Medicare beneficiaries aged 15 to 65, beneficiaries outside that age range who are at increased risk, and pregnant women. The "increased risk" designation is doing a lot of work in that sentence. It includes people who use injection drugs, men who have sex with men, people with multiple sexual partners, and people whose partners are HIV-positive. Your documentation needs to reflect the clinical basis for the test.

Medicare covers up to one screening per year for at-risk beneficiaries and up to three screenings during a pregnancy. That frequency limit is a real claim denial trigger. If your team isn't tracking prior screenings within the same calendar year, you're billing blind.

The medical necessity bar here is not high—but it is specific. A beneficiary doesn't need symptoms. They don't need a diagnosis code pointing to HIV risk. But the encounter documentation should reflect that the patient falls into a covered category. "Routine screening" without supporting context is a red flag on audit.

Prior authorization is not required for Medicare HIV screening under the preventive services benefit. That's good news operationally. But the absence of prior authorization doesn't mean there's no review. CMS and Medicare Administrative Contractors can retrospectively audit claims and deny reimbursement if documentation doesn't support the screening indication.

If your practice sees a high volume of Medicare patients and you're not auditing HIV screening claims at least quarterly, you're carrying unnecessary risk.

CMS HIV Screening Exclusions and Non-Covered Indications

Not every HIV-related test qualifies under this coverage policy. CMS draws a clear line between screening and diagnostic testing.

A screening test is for a patient with no known HIV infection and no current symptoms pointing to HIV. A diagnostic test is ordered because the clinician suspects infection based on clinical presentation. Those two scenarios bill differently and reimburse differently. Submitting a diagnostic test under the screening benefit is a billing error that creates fraud exposure—not just a claim denial.

Confirmatory testing after a reactive screening result is not covered under the preventive screening benefit. A reactive rapid HIV test followed by a confirmatory Western blot or RNA test moves out of the preventive benefit and into diagnostic territory. Your billing team needs to understand that distinction before the first claim goes out.

HIV monitoring tests for patients with known HIV infection are also not covered under this screening benefit. Those tests—viral load, CD4 counts—fall under separate coverage rules. If your practice manages HIV-positive patients and your billing team is conflating screening with monitoring, that's a problem worth fixing before May 15, 2026.

Coverage Indications at a Glance

CMS HIV Screening Billing Guidelines and Action Items 2026

The effective date of May 15, 2026 is your deadline for getting your workflows in order. Here's what to do before then.

CPT, HCPCS, and ICD-10 Codes for HIV Screening Under This CMS Policy

This policy does not list specific CPT, HCPCS, or ICD-10 codes in the available policy data. Do not assume standard codes are unchanged.

The absence of published codes in this policy update is a billing risk on its own. CMS HIV screening billing has historically used specific HCPCS codes that vary by test type and setting. The fact that this modification does not enumerate them doesn't mean your team gets to pick freely.

Your action here: pull the current CMS billing guidelines for HIV screening directly from your Medicare Administrative Contractor's website. Different MACs sometimes publish local coverage determinations or billing articles that specify the exact codes to use in your region. What's acceptable in one MAC jurisdiction may not be in another.

Until you have MAC-confirmed codes in hand, do not assume your current charge capture is correct for claims submitted on or after May 15, 2026.

If you have a revenue cycle consultant or coding specialist with Medicare preventive services experience, loop them in now—not after the effective date.